NIH-funded research R01 grant

Understanding Nerve Signals in Pain and Abnormal Bone Growth

Official title: ACVR1 sensory neuron-specific signaling in neuropathic pain and injury-induced heterotopic ossification

Funded at University of California, San Francisco · NIH-11143096 · Data updated 2026-11-12

This project explores how specific nerve signals contribute to long-lasting pain and abnormal bone formation, hoping to find new ways to help people with these conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 1, 2023
Project endJune 30, 2028
Funding year2025
Award (this year)$405,701
NIH project number5R01AR081964-03
Project IDNIH-11143096 on NIH RePORTER

Who could benefit from this research

Could help

Patients experiencing chronic pain related to nerve issues or abnormal bone growth, particularly those with conditions like Fibrodysplasia Ossificans Progressiva (FOP), could ultimately benefit from this foundational understanding.

Less likely to help

Patients whose pain or bone conditions are not related to ACVR1 signaling in sensory neurons may not directly benefit from this specific line of research.

What this research studies

Many people experience severe pain and a condition called heterotopic ossification (HO), where extra bone grows in soft tissues after injuries or surgeries, and current treatments are limited. This project aims to understand how specific signals within our sensory nerves contribute to both this persistent pain and the abnormal bone growth. We are particularly interested in a gene called ACVR1, which is known to cause a rare bone condition called FOP, where patients often have increased pain sensitivity. By studying nerve cells derived from FOP patients, we hope to uncover the exact ways these signals lead to pain and HO, paving the way for new and more effective therapies.

Why it matters

Potential benefit: If successful, this work could lead to new treatments that specifically target the nerve signals responsible for chronic pain and abnormal bone growth, offering relief to many patients.

How similar studies have gone: While the exact mechanisms are not fully understood, previous work on FOP and nerve-bone interactions provides a foundation for this novel approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Yu, Xiaobing — University of California, San Francisco
  • Study coordinator: Yu, Xiaobing

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.